This Figure illustrates the crude incidence rates of fatal and non-fatal bleeding, from the previous Figure, according to antithrombotic regimen per time period following enrollment.  The results clearly show that the patients on triple therapy have a much higher bleeding rate than do patients on other combinations of antiplatelet and antithrombin therapies.[134]

French WJ. Am J Med 2013; 126: 00-00.